.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Ischemic stroke remains a leading cause of disability globally. Consequently, researchers are exploring novel therapeutic agents to mitigate brain damage. Recent evidence highlights the potential for leptin neuroprotection in stroke recovery. Leptin, primarily known for regulating appetite, acts as a potent signaling molecule in the central nervous system. A comprehensive systematic review of 17 preclinical studies involving 1,383 animals reveals that leptin administration significantly reduces brain injury.
Specifically, the hormone triggers several pro-survival signaling cascades. The analysis identified the PI3K/Akt and JAK/STAT3 pathways as critical drivers of these protective effects. These pathways help maintain cell viability by inhibiting apoptosis and reducing oxidative stress. Furthermore, leptin promotes neurogenesis and angiogenesis, which are vital for long-term functional recovery. Therefore, the hormone does not only prevent cell death but also supports the brain's natural repair mechanisms.
Notably, the meta-analysis demonstrated a significant reduction in infarct volume, with a standardized mean difference of -2.76. Beyond structural preservation, leptin also improves neurobehavioral outcomes. Animals treated with leptin showed enhanced motor coordination and sensory function. These findings suggest that leptin could provide a dual benefit by protecting tissue and improving quality of life. However, translating these rodent-based successes into human clinical trials remains the next major challenge for the scientific community.
While the preclinical data is robust, researchers must optimize delivery methods and dosage for humans. Identifying the therapeutic window is essential, as the timing of administration significantly impacts efficacy. Additionally, understanding how leptin interacts with existing therapies like thrombolysis will be crucial. Researchers are optimistic that metabolic hormones could eventually become a cornerstone of acute stroke management.
Leptin activates specific pathways, such as PI3K/Akt and JAK/STAT3, which prevent cell death and promote the growth of new blood vessels and neurons.
No, the current evidence is primarily based on preclinical animal models. Clinical trials are needed to confirm the safety and efficacy of leptin in humans.
Yes, meta-analyses show that leptin administration significantly reduces the volume of infarcted (damaged) brain tissue in rodent models of ischemia.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice. Refer to the latest local and national guidelines for clinical practice.
References
Behrouzifar S et al. Leptin-induced neuroprotection in ischemic stroke: a comprehensive systematic review and meta-analysis elucidating molecular pathways in preclinical animal models. Brain Inj. 2026 Feb 28. doi: 10.1080/02699052.2026.2636708. PMID: 41761843.
Amantea D et al. Neuroprotection by leptin in a rat model of permanent cerebral ischemia: Effects on STAT3 phosphorylation. Neurobiology of Disease. 2011.
Avraham Y et al. Leptin induces neurogenesis and angiogenesis after stroke. PubMed. 2011.
"
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Research confirms that leptin significantly reduces brain infarct volume and enhances motor function recovery in animal models through key molecular pathway...
7 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
